The IMID Forum
The Immune-Mediated Inflammatory Disease Forum
Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.
Episodes
Mentioned books

Jun 4, 2021 • 32min
Insights at EULAR 2021: Day 3 Highlights
Professor Douglas Veale presents the Day 3 highlights of the key abstracts and posters presented at EULAR 2021.

Jun 3, 2021 • 19min
Insights at EULAR 2021: Day 2 Highlights
Dr Elena Nikiphorou presents the Day 2 highlights of the key abstracts and posters presented at EULAR 2021.

Jun 2, 2021 • 25min
Insights at EULAR 2021: Day 1 Highlights
Prof Veale presents the Day 1 highlights of the key abstracts and posters presented at EULAR 2021.

Jun 1, 2021 • 14min
Insights at EULAR 2021: Preview
A preview of the latest research at EULAR 2021.
Prof Edwards presents a preview of the upcoming EULAR 2021 congress, highlighting important abstracts and posters in cytokine signalling.

May 28, 2021 • 9min
Discussing Rheumatology: PsA and Radiographic Progression
Prof Iain McInnes discusses upadacitinib in PsA, and radiographic progression with tofacitinib.
Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.

May 13, 2021 • 29min
Rheumatology Author Professor Yoshiya Tanaka: Filgotinib
Yoshiya Tanaka, Professor and Chairman of the department of Internal Medicine at the University of Occupational and Environmental Health in Kitakyushu, Japan. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Tanaka discusses the safety and efficacy of filgotinib as a Novel JAK1-Preferential Inhibitor for the Treatment of RA.

Apr 28, 2021 • 32min
Rheumatology Author Dr Rishi Desai: VTE
Dr Rishi Desai, is an Assistant Professor of Medicine at Harvard Medical School and an Associate Epidemiologist in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Dr Rishi Desai discusses Risk of venous thromboembolism associated with tofacitinib in patients with RA

Apr 28, 2021 • 8min
Discussing Rheumatology: JAKi and VTE
Prof Iain McInnes discusses JAKi and thromboembolism
Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.

Apr 1, 2021 • 38min
Rheumatology Author Dr Ben Nowell: ArthritisPower
Dr Ben Nowell, Director of Patient-Centred Research at CreakyJoints, part of the Global Healthy Living Foundation. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Dr Ben Nowell a real-world longitudinal study in ArthritisPower

Mar 17, 2021 • 8min
Discussing Rheumatology: Bone and PRO
Prof Iain McInnes discusses bone metabolism and PRO
Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.


